Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland

International Journal of Cancer. Journal International Du Cancer
Heini SaloA Anttila

Abstract

We evaluated the overall coverage, frequency and costs of Pap testing by screening modality and health care provider in Finland. Information about Pap testing in the Finnish female population of 2.7 million was obtained from nationwide population-based registry data. Among women aged 25-69 years, 87% had had a Pap test taken within or outside the organised programme at least once during the last 5 years and half of those screened in the organised programme had also had at least one Pap test taken outside the programme. Of the annual average of 530,000 Pap tests taken, 84% were taken for screening purposes and 16% as follow-up. Forty percent of the 446,000 annual screening tests were taken in the organised programme, 55% as opportunistic tests in public primary or student health care or by private providers and 5% in public secondary health care. One-fifth of all opportunistic screening Pap tests were taken from women aged <25. The voluminous opportunistic Pap testing in public primary health care was concentrated in young women aged 25-29 whereas the bulk of opportunistic testing in private health occurred in age groups eligible for organised screening. The total cost of all screening Pap tests was €22.4 million, of which 71% i...Continue Reading

References

Dec 1, 1977·British Journal of Preventive & Social Medicine·M Hakama, E Pukkala
Apr 1, 1995·International Journal of Epidemiology·G J van Oortmarssen, J D Habbema
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P NieminenM Hakama
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·A AnttilaM Hakama
Jul 18, 2003·The Journal of General Virology·Päivi LaukkanenMatti Lehtinen
Jul 29, 2004·British Journal of Cancer·A AnttilaE Weiderpass
Nov 9, 2004·Lancet·Anna-Barbara MoscickiTeresa M Darragh
Sep 23, 2006·International Journal of Cancer. Journal International Du Cancer·Matti LehtinenPentti Koskela
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Matejka ReboljDik Habbema
Aug 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ahti AnttilaGuglielmo Ronco
Aug 29, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Guglielmo RoncoAhti Anttila
Sep 12, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ahti AnttilaUNKNOWN Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the E
Feb 9, 2010·Journal of the National Cancer Institute·Nubia MuñozRichard M Haupt
Feb 24, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ArbynL von Karsa
Jul 14, 2010·International Journal of Cancer. Journal International Du Cancer·Inge M C M de KokUNKNOWN Working Group Output of the Netherlands Cancer Registry
Jul 30, 2010·International Journal of Cancer. Journal International Du Cancer·Anni VirtanenPekka Nieminen
Jul 15, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anni VirtanenAhti Anttila
Mar 7, 2013·International Journal of Cancer. Journal International Du Cancer·Heini SaloPekka Nieminen

❮ Previous
Next ❯

Citations

Sep 2, 2015·Nature Reviews. Clinical Oncology·F Xavier BoschJack Cuzick
Sep 3, 2014·International Journal of Cancer. Journal International Du Cancer·Anni VirtanenPekka Nieminen
Jan 12, 2017·Journal of Medical Screening·Maiju PankakoskiAhti Anttila
Mar 27, 2019·PloS One·Maiju PankakoskiSirpa Heinävaara
Apr 24, 2018·European Journal of Public Health·Mireia DiazSilvia de Sanjosé
Dec 15, 2019·International Journal of Environmental Research and Public Health·Justina PaulauskieneJanina Petkeviciene
Oct 18, 2020·International Journal of Environmental Research and Public Health·Esther E IdehenMari Kangasniemi
Jan 15, 2021·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Johanna PulkkinenIvana Kholová
Nov 1, 2020·International Journal of Environmental Research and Public Health·Esther E IdehenPäivikki Koponen
Sep 8, 2021·European Journal of Public Health·Julianne WilliamsJoão Breda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.